PillSeek

Reviewed by PillSeek Editorial Team · Last updated

Atripla

Efavirenz 600 mg;emtricitabine 200 mg;tenofovir disoproxil fumarate 300 mg;

About This Medication

This medication is a Pink Oval 20 mm, Film coated tablet with imprint "123". It contains Efavirenz 600 mg;emtricitabine 200 mg;tenofovir disoproxil fumarate 300 mg; of Efavirenz[efavirenz];emtricitabine[emtricitabine];tenofovir disoproxil fumarate[tenofovir anhydrous];. This belongs to the Human immunodeficiency virus 1 non-nucleoside analog reverse transcriptase inhibitor pharmacologic class. It is manufactured by Gilead Sciences, LLC. For details please contact your physician.

Basic Information

Imprint
123
Color
Pink
Shape
Oval
Size
20 mm

Drug Information

Strength
Efavirenz 600 mg;emtricitabine 200 mg;tenofovir disoproxil fumarate 300 mg;
Dosage Form
Film coated tablet
RxCUI
643070

Related Medications

Other drugs in the same class: Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor

Ingredients

Active Ingredients
Efavirenz[efavirenz];emtricitabine[emtricitabine];tenofovir disoproxil fumarate[tenofovir anhydrous];
Inactive Ingredients
Croscarmellose sodium;hydroxypropyl cellulose (1600000 wamw);magnesium stearate;microcrystalline cellulose;sodium lauryl sulfate;ferrosoferric oxide;polyethylene glycol 3350;polyvinyl alcohol, unspecified;ferric oxide red;talc;titanium dioxide;

Additional Information

Manufacturer
Gilead Sciences, LLC
Status (Rx/OTC)
Rx
Brand Names
Atripla

⚠️ Important: This information is for educational purposes only. Do not use this tool for medical diagnosis or treatment decisions. Always consult your pharmacist or healthcare provider for questions about your medications. Read full medical disclaimer.

Pink Oval Atripla Efavirenz 600 mg;emtricitabine 200 mg;tenofovir disoproxil fumarate 300 mg; Pill With Imprint 123 | PillSeek